Domain fusion modulates antibody recognition without altering the parental scFv sequence for multi-residue screening of β-lactam antibiotics under MRL constraints
Biosensors and Bioelectronics · 2027-02 · 317 · 119371
DOI: 10.1016/j.bios.2026.119371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2027-02. Verfasst von Hao Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory for the Detection of Veterinary Drug Residues, Huazhong Agric…. Hauptthemen laut MEDLINE: Single-Chain Antibodies, Biosensing Techniques, beta-Lactams. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Hubei Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Broad-spectrum detection of structurally diverse small molecules is often limited by the trade-off between specificity and recognition breadth. Here, we present a domain fusion strategy to modulate antibody recognition behavior without altering the parental scFv sequence. A bifunctional fusion protein, BlaR-M-scFv, was engineered by integrating receptor- and antibody-based recognition within a single framework, enabling broad-spectrum screening of β-lactam antibiotics at regulatory maximum residue limits (MRLs) in complex matrices. The fusion protein exhibited an expanded recognition spectrum compared with the parental scFv, indicating altered recognition behavior. Domain separation experiments showed that the isolated domains retained their characteristic recognition properties, consistent with a contribution of interdomain coupling to the altered recognition behavior. Molecular dynamics (MD) simulations suggested that fusion was associated with remodeling of the scFv conformational landscape, resulting in a more constrained yet spatially permissive state. In the ligand-bound state, structural and energetic analyses suggested a redistribution of interaction networks and altered interaction geometry. These changes are consistent with increased tolerance toward structural variation among β-lactam antibiotics, accompanied by reduced apparent recognition strength for the specific ligand cefalexin compared with the parental scFv under the same assay conditions. This work suggests that domain fusion may provide a means of modulating antibody recognition through conformational regulation and offers a potential strategy for developing multi-residue screening immunoassays for β-lactam antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory for the Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, 430070, China.
- College of Life Sciences, Chongqing Normal University, Chongqing, 401331, China.
- Animal Husbandry Technology Promotion Station of Zhejiang Province, Hangzhou, Zhejiang, 310021, China.
- National Reference Laboratory of Veterinary Drug Residues (HZAU) and MOA Key Laboratory for the Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan, 430070, China. Electronic address: lilong@m…
- Zhejiang Provincial Engineering Research Center of Animal Biological Products, Center for Veterinary Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China. Electronic address: pengdapeng@zju.edu.cn.
Förderung
- Hubei Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wen, H., Ding, M., Jiang, S., Wen, D., Zhang, L., Yang, H., Wu, S., Chen, J., Wang, X., Li, L., & Peng, D. (2027). Domain fusion modulates antibody recognition without altering the parental scFv sequence for multi-residue screening of β-lactam antibiotics under MRL constraints. Biosensors and Bioelectronics, 317, 119371. https://doi.org/10.1016/j.bios.2026.119371
Vancouver
Wen H, Ding M, Jiang S, Wen D, Zhang L, Yang H, et al. Domain fusion modulates antibody recognition without altering the parental scFv sequence for multi-residue screening of β-lactam antibiotics under MRL constraints. Biosensors and Bioelectronics. 2027;317:119371. doi:10.1016/j.bios.2026.119371
BibTeX
@article{Wen2027,
author = {Wen, Hao and Ding, Mingyue and Jiang, Shuang and Wen, Defeng and Zhang, Linwei and Yang, Hongfei and Wu, Shixiang and Chen, Jie and Wang, Xu and Li, Long and Peng, Dapeng},
title = {Domain fusion modulates antibody recognition without altering the parental scFv sequence for multi-residue screening of β-lactam antibiotics under MRL constraints},
journal = {Biosensors and Bioelectronics},
year = {2027},
volume = {317},
pages = {119371},
doi = {10.1016/j.bios.2026.119371}
}
EUVIMED